| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.04 |